Unduh Oncology Nursing Drug Handbook - v3.5.13

Ada cukup banyak Aplikasi sebagus X-RAY WOW, Medical Dictionary Free & Offline - Diseases, Patchwork, iDentist Dental practice management, Pacify, Dexcom G6, dan Oncology Nursing Drug Handbook - v3.5.13 juga, salah satu Aplikasi terbaik dari genre Kedokteran.

Dikembangkan oleh Skyscape Medpresso Inc, Oncology Nursing Drug Handbook - v3.5.13 memerlukan versi Android setidaknya Android 5.0+. Oleh karena itu, Anda harus memperbarui ponsel Anda jika perlu.

Oncology Nursing Drug Handbook - v3.5.13 APK versi terbaru adalah 3.5.13, tanggal rilis 2020-06-25, dan memiliki ukuran 8.4 MB.

Statistik tentang 1000 unduhan tersedia dari Google Play. Anda dapat memperbarui aplikasi yang telah diunduh atau dipasang satu per satu pada perangkat Android Anda jika Anda mau. Memperbarui aplikasi memberi Anda lebih banyak akses ke fitur terbaru dan meningkatkan keamanan dan stabilitas aplikasi.

Karena tidak semua game atau aplikasi kompatibel untuk semua ponsel. Dan game atau aplikasi tidak tersedia untuk perangkat Anda, itu tergantung pada versi OS Android, resolusi layar, atau negara tempat Google Play mengizinkan aksesnya. Jadi di APK4Share Anda dapat mengunduh file APK dengan mudah dan tidak tunduk pada batasan ini.

Written especially for nurses caring for patients with cancer, the 2020-2021 Oncology Nursing Drug Handbook uniquely expresses drug therapy in terms of the nursing process: nursing diagnoses, etiologies of toxicities, and key points for nursing assessment, intervention, and evaluation. This essential reference provides valuable information on effective symptom management, patient education, and chemotherapy administration.

DESCRIPTION
Completely revised and updated, the 2020-2021 Oncology Nursing Drug Handbook includes separate chapters on molecular and immunologic/biologic targeted therapies. These chapters provide fundamental reviews to assist nurses in understanding the cellular communication pathways disrupted by cancer. It also offers simplified content, attention to understanding the immune checkpoint inhibitors, new information about immunotherapy, new drugs and their indications, and updated indications and side effects for drugs recently approved by the FDA.

Key Features

- Provides valuable information on effective symptom management, patient education, and chemotherapy administration.
- Completely revised and updated, includes separate chapters on molecular and immunologic/biologic targeted therapies
- Provides fundamental reviews to assist nurses in understanding the cellular communication pathways disrupted by cancer
- Offers simplified content, attention to understanding the immune checkpoint inhibitors, new information about immunotherapy, new drugs and their indications, and updated indications and side effects for recently FDA approved drugs
- New drugs include: apalutamide (Erleada™), calaspargase pegol-mknl (Asparlas™), Daunorubicin and cytarabine liposome for injection (Vyxeos®), glucarpidase (Voraxaze®), alpelisib (Piqray®), binimetinib (Mektovi®), dacomitinib (Vizimpro®), Duvelisib (Copiktra®), encorafenib (Braftovi®), erdafitinib (Balversa™), lorlatinib (Lorbrena®), anakinra (Kineret®), baricitinib (Olumiant®), sarilumab (Kevzara®), aprepitant injectable emulsion (Cinvanti®), granisetron hydrochloride extended-release injection (Sustol®), letermovir (Prevymis™), omadacycline (Nuzyra™), meropenem/vaborbactam (Vabomere™), Plazomicin (Zemdri™), baloxavir marboxil (Xofluza™), imipenem/cilastatin sodium/relebactam (Recarbrio™), eravacycline (Xerava™), delafloxacin (Baxdela™)

Faster download with slow internet connectivity